clorgyline has been researched along with Affective Disorders in 1 studies
Clorgyline: An antidepressive agent and monoamine oxidase inhibitor related to PARGYLINE.
clorgyline : An aromatic ether that is the 2,4-dichlorophenyl ether of 3-aminopropan-1-ol in which the nitrogen is substituted by a methyl group and a prop-1-yn-3-yl group. A monoamine oxidase inhibitor, it was formerly used as an antidepressant.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garcia-Miralles, M | 1 |
| Ooi, J | 1 |
| Ferrari Bardile, C | 1 |
| Tan, LJ | 1 |
| George, M | 1 |
| Drum, CL | 1 |
| Lin, RY | 1 |
| Hayden, MR | 1 |
| Pouladi, MA | 1 |
1 other study available for clorgyline and Affective Disorders
| Article | Year |
|---|---|
Treatment with the MAO-A inhibitor clorgyline elevates monoamine neurotransmitter levels and improves affective phenotypes in a mouse model of Huntington disease.
Topics: Animals; Brain; Clorgyline; Disease Models, Animal; Exploratory Behavior; Hindlimb Suspension; Human | 2016 |